News

TORONTO, ONTARIO / ACCESS Newswire / August 11, 2025 / As food companies race to meet evolving regulations and rising ...
NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Zurich auf "Hold" mit einem Kursziel von 445 Franken belassen. Der Versicherungssektor habe im vergangenen Monat gut abge ...
Forscher der Universität Bayreuth und der Hong Kong University of Science and Technology haben erstmals ein KI-basiertes Multiagentensystem zur Entwicklung neuer Elektrolyte eingesetzt. Durch diesen A ...
Newron Pharmaceuticals meldet, dass neue präklinische Forschungsergebnisse zu Evenamide in der Fachzeitschrift Neuropsychopharmacology veröffentlicht wurden. Die Untersuchung der University of Pittsbu ...
Mutares hat eine Vereinbarung zur Übernahme des Kranbereichs von Hyva unterzeichnet. Die Akquisition soll das Segment Goods & Services als neue Plattforminvestition stärken und vorbehaltlich der karte ...
NORWALK (dpa-AFX) - Xerox Holdings Corp. (XRX) announced Monday that President and Chief Operating Officer John Bruno has decided to pursue a CEO opportunity outside of Xerox. Louie Pastor has ...
HIGH POINT, N.C., Aug. 11, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company focused on the development of cadisegliatin, a potential first-in-class ...
Learn how to buy Cow Protocol (COW) in 2025 using exchanges or CoW Swap, while minimizing fees and slippage. Understand wallets, risks, and governance to make informed COW purchases. With growing dema ...
SAN BERNARDINO COUNTY, CA / ACCESS Newswire / August 11, 2025 / Dateline Resources Limited (ASX:DTR)(OTCQB:DTREF) ("Dateline" or the "Company"), a North America-focused mining and exploration company, ...
Appointment supports multi-building, multi-product ramp-up in Orlando ORLANDO, FL / ACCESS Newswire / August 11, 2025 / Unusual Machines (NYSE AMERICAN:UMAC), a leading provider of NDAA-compliant dron ...
XWELL, Inc. (Nasdaq: XWEL), a leading provider of wellness solutions for people on the go, today announced that it has received formal notice from The Nasdaq ...
Positive interim Phase 1b update underscores firmonertinib's potential in EGFR PACC mutant NSCLC; global pivotal Phase 3 ALPACCA study expected to enroll first patient in 2H 2025Dosed the first patien ...